Di Marco F - Search Results

1

The role of cefditoren in the treatment of lower community-acquired respiratory tract infections (LRTIs): from bacterial eradication to reduced lung inflammation and epithelial damage.

Di Marco F, Braido F, Santus P, Scichilone N, Blasi F. Di Marco F, et al. Eur Rev Med Pharmacol Sci. 2014;18(3):321-32. Eur Rev Med Pharmacol Sci. 2014. PMID: 24563430 Free article. Review.

2

Lung function improvement in smokers suffering from COPD with zafirlukast, a CysLT(1)-receptor antagonist.

Cazzola M, Boveri B, Carlucci P, Santus P, DiMarco F, Centanni S, Allegra L. Cazzola M, et al. Pulm Pharmacol Ther. 2000;13(6):301-5. doi: 10.1006/pupt.2000.0258. Pulm Pharmacol Ther. 2000. PMID: 11061985 Clinical Trial.

3

Evaluation of the effects of zafirlukast 40 mg b.i.d. in addition to preexisting therapy of high-dose inhaled steroids on symptomatic patients with reversible respiratory obstruction: preliminary data.

Centanni S, Santus P, Casanova F, Di Marco F, Brazzola G, Canonica GW. Centanni S, et al. Among authors: di marco f. Drugs Exp Clin Res. 2000;26(4):133-8. Drugs Exp Clin Res. 2000. PMID: 11109513

4

Onset of action of single doses of formoterol administered via Turbuhaler in patients with stable COPD.

Cazzola M, Centanni S, Regorda C, di Marco F, di Perna F, Carlucci P, Boveri B, Santus P. Cazzola M, et al. Among authors: di marco f, di perna f. Pulm Pharmacol Ther. 2001;14(1):41-5. doi: 10.1006/pupt.2000.0267. Pulm Pharmacol Ther. 2001. PMID: 11162418 Clinical Trial.

5

The potential role of tocopherol in asthma and allergies: modification of the leukotriene pathway.

Centanni S, Santus P, Di Marco F, Fumagalli F, Zarini S, Sala A. Centanni S, et al. Among authors: di marco f. BioDrugs. 2001;15(2):81-6. doi: 10.2165/00063030-200115020-00002. BioDrugs. 2001. PMID: 11437677 Review.

6

Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease.

Cazzola M, Centanni S, Boveri B, Di Marco F, Santus P, Matera MG, Allegra L. Cazzola M, et al. Among authors: di marco f. Respiration. 2001;68(5):452-9. doi: 10.1159/000050550. Respiration. 2001. PMID: 11694805 Clinical Trial.

7

Atopy prevalence and spirometric performance in asymptomatic schoolchildren exposed to air pollution.

Centanni S, Di Marco F, Castagna F, Santus P, Guarnieri R, Allegra L. Centanni S, et al. Among authors: di marco f. Monaldi Arch Chest Dis. 2001 Aug;56(4):304-8. Monaldi Arch Chest Dis. 2001. PMID: 11770209

8

Bronchodilating effect of oxitropium bromide in heart disease patients with exacerbations of COPD: double-blind, randomized, controlled study.

Centanni S, Santus P, Casanova F, Carlucci P, Boveri B, Castagna F, Di Marco F, Cazzola M. Centanni S, et al. Among authors: di marco f. Respir Med. 2002 Mar;96(3):137-41. doi: 10.1053/rmed.2001.1219. Respir Med. 2002. PMID: 11905547 Free article. Clinical Trial.

9

Addition of an extra dose of salmeterol Diskus to conventional dose of salmeterol Diskus in patients with COPD.

Cazzola M, Santus P, Castagna F, Di Marco F, Terzano C, Matera MG, Centanni S. Cazzola M, et al. Among authors: di marco f. Respir Med. 2002 Jun;96(6):439-43. doi: 10.1053/rmed.2001.1279. Respir Med. 2002. PMID: 12117044 Free article. Clinical Trial.

10

Bronchodilation test in COPD: effect of inspiratory manoeuvre preceding forced expiration.

Santus P, Pecchiari M, Carlucci P, Boveri B, Di Marco F, Castagna F, Centanni S. Santus P, et al. Among authors: di marco f. Eur Respir J. 2003 Jan;21(1):82-5. doi: 10.1183/09031936.03.00052203a. Eur Respir J. 2003. PMID: 12570113 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

312 results

Search Page

Filters